CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Net Income Growth by Quarter and Year

Atara Biotherapeutics Inc 's Net Income results by quarter and year




ATRA Net Income (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December -80.01 -35.31 -18.24 -21.25
III Quarter September -58.36 -31.10 -25.37 -11.87
II Quarter June -50.88 -27.43 -18.88 -14.95
I Quarter March -41.44 -25.65 -16.56 -9.16
FY   -230.69 -119.49 -79.05 -57.23



ATRA Net Income forth quarter 2017 Y/Y Growth Comment
Atara Biotherapeutics Inc in the forth quarter recorded net loss of $ -80.01 millions.

According to the results reported in the forth quarter, Atara Biotherapeutics Inc achieved the best Net Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics Inc ' s Net Income no change of % ranks overall at the positon no. in the forth quarter.




ATRA Net Income ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics Inc 's forth quarter 2017 Net Income $ -80.01 millions ATRA's Income Statement
Atara Biotherapeutics Inc 's forth quarter 2016 Net Income $ -35.31 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Net Income Growth >>


ATRA Net Income (Quarter on Quarter Growth %)

2017
2016 2015 2014
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income forth quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income forth quarter 2017 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2014, 2015, 2016, 2017

Atara Biotherapeutics Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Net Income Comment
Recent net loss of -80.01 millions by Atara Biotherapeutics Inc look even less good considering the -58.36 millions net loss a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Net Income growth. While Atara Biotherapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's IV. Quarter Q/Q Net Income Comment
Recent accomplishment of -80.01 millions by Atara Biotherapeutics Inc appear even worse compare to the -58.36 millions in the third quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics Inc achieved highest sequential Net Income growth. While Atara Biotherapeutics Inc 's Net Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
In the period, Atara Biotherapeutics Inc 's cumulative trailing twelve month Net Income remained unchanged compare to the same period a year ago.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
In the period, Atara Biotherapeutics Inc 's cumulative trailing twelve month Net Income remained unchanged compare to the same period a year ago.

Atara Biotherapeutics Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ATRA's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ATRA's Competitors
Net Income Growth for Atara Biotherapeutics Inc 's Suppliers
Net Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Dec 31 2018 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2018
Biospecifics Technologies Corp  203.87 %$ 203.868 millions
Harvard Bioscience Inc  186.49 %$ 186.486 millions
Neurocrine Biosciences Inc   162.23 %$ 162.228 millions
Lifevantage Corp  161.51 %$ 161.514 millions
Cellect Biotechnology Ltd.  147.06 %$ 147.058 millions
Icon Plc  144.16 %$ 144.156 millions
Ensign Group Inc  136.67 %$ 136.669 millions
Mettler toledo International Inc   135.38 %$ 135.380 millions
Idexx Laboratories Inc  123.76 %$ 123.758 millions
Enanta Pharmaceuticals Inc   122.45 %$ 122.449 millions
Phibro Animal Health Corp  109.73 %$ 109.727 millions
Contrafect Corp  102.16 %$ 102.157 millions
Medpace Holdings inc   101.59 %$ 101.585 millions
Dermtech Inc   100.06 %$ 100.061 millions
Hca Healthcare Inc   94.23 %$ 94.228 millions
Supernus Pharmaceuticals inc   89.58 %$ 89.581 millions
China Biologic Products Holdings Inc   79.93 %$ 79.930 millions
Glaukos Corp  76.84 %$ 76.839 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SGLB's Profile

Stock Price

SGLB's Financials

Business Description

Fundamentals

Charts & Quotes

SGLB's News

Suppliers

SGLB's Competitors

Customers & Markets

Economic Indicators

SGLB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071